| Three‐dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe A Hammers, R Allom, MJ Koepp, SL Free, R Myers, L Lemieux, ... Human brain mapping 19 (4), 224-247, 2003 | 1413 | 2003 |
| In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease A Gerhard, N Pavese, G Hotton, F Turkheimer, M Es, A Hammers, ... Neurobiology of disease 21 (2), 404-412, 2006 | 1309 | 2006 |
| Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study C Menni, K Klaser, A May, L Polidori, J Capdevila, P Louca, CH Sudre, ... The Lancet Infectious Diseases 21 (7), 939-949, 2021 | 1189 | 2021 |
| Multi-atlas based segmentation of brain images: atlas selection and its effect on accuracy P Aljabar, RA Heckemann, A Hammers, JV Hajnal, D Rueckert Neuroimage 46 (3), 726-738, 2009 | 1160 | 2009 |
| Automatic anatomical brain MRI segmentation combining label propagation and decision fusion RA Heckemann, JV Hajnal, P Aljabar, D Rueckert, A Hammers NeuroImage 33 (1), 115-126, 2006 | 1130 | 2006 |
| Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study M Antonelli, RS Penfold, J Merino, CH Sudre, E Molteni, S Berry, ... The Lancet Infectious Diseases 22 (1), 43-55, 2022 | 937 | 2022 |
| Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective … C Menni, AM Valdes, L Polidori, M Antonelli, S Penamakuri, A Nogal, ... The Lancet 399 (10335), 1618-1624, 2022 | 915 | 2022 |
| Gan augmentation: Augmenting training data using generative adversarial networks C Bowles, L Chen, R Guerrero, P Bentley, R Gunn, A Hammers, ... arXiv preprint arXiv:1810.10863, 2018 | 631 | 2018 |
| Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R) PK11195-PET and [11C] PIB-PET study P Edison, HA Archer, A Gerhard, R Hinz, N Pavese, FE Turkheimer, ... Neurobiology of disease 32 (3), 412-419, 2008 | 622 | 2008 |
| Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C] PIB and [18F] FDG PET study P Edison, HA Archer, R Hinz, A Hammers, N Pavese, YF Tai, G Hotton, ... Neurology 68 (7), 501-508, 2007 | 621 | 2007 |
| Random forest-based similarity measures for multi-modal classification of Alzheimer's disease KR Gray, P Aljabar, RA Heckemann, A Hammers, D Rueckert, ... NeuroImage 65, 167-175, 2013 | 538 | 2013 |
| Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2 E Molteni, CH Sudre, LS Canas, SS Bhopal, RC Hughes, M Antonelli, ... The Lancet Child & Adolescent Health 5 (10), 708-718, 2021 | 485 | 2021 |
| Diffeomorphic registration using B-splines D Rueckert, P Aljabar, RA Heckemann, JV Hajnal, A Hammers Medical Image Computing and Computer-Assisted Intervention–MICCAI 2006: 9th …, 2006 | 449 | 2006 |
| Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest IS Gousias, D Rueckert, RA Heckemann, LE Dyet, JP Boardman, ... Neuroimage 40 (2), 672-684, 2008 | 411 | 2008 |
| Mapping neurotransmitter systems to the structural and functional organization of the human neocortex JY Hansen, G Shafiei, RD Markello, K Smart, SML Cox, M Nørgaard, ... Nature neuroscience 25 (11), 1569-1581, 2022 | 385 | 2022 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 374 | 2021 |
| Reference and target region modeling of [11C]-(R)-PK11195 brain studies FE Turkheimer, P Edison, N Pavese, F Roncaroli, AN Anderson, ... Journal of Nuclear Medicine 48 (1), 158-167, 2007 | 345 | 2007 |
| LEAP: learning embeddings for atlas propagation R Wolz, P Aljabar, JV Hajnal, A Hammers, D Rueckert, ... NeuroImage 49 (2), 1316-1325, 2010 | 302 | 2010 |
| Cortical dysfunction in non-demented Parkinson's disease patients: A combined 31P-MRS and 18FDG-PET study MTM Hu, SD Taylor-Robinson, KR Chaudhuri, JD Bell, C Labbe, ... Brain 123 (2), 340-352, 2000 | 294 | 2000 |
| Diagnostic accuracy of 18F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis E Morris, A Chalkidou, A Hammers, J Peacock, J Summers, S Keevil European journal of nuclear medicine and molecular imaging 43 (2), 374-385, 2016 | 279 | 2016 |
Rolf A. HeckemannDepartment of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska AcademyVerified email at gu.se